meta_pixel
Tapesearch Logo
Log in
Huberman Lab

Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity

Huberman Lab

Scicomm Media

Science, Health & Fitness, Life Sciences

4.826.2K Ratings

🗓️ 7 August 2023

⏱️ 103 minutes

🧾️ Download transcript

Summary

In this episode, I explain how ketamine causes rewiring of brain circuits and dissociative states to relieve symptoms of depression and post-traumatic stress disorder (PTSD). I explain how ketamine impacts both the brain’s glutamate and its endogenous opioid pathways, which together regulate mood and well-being. I discuss how ketamine therapy is used clinically to treat major depression, bipolar depression, obsessive-compulsive disorder (OCD), suicidality and other psychiatric challenges. I also describe how ketamine causes the subjective effects of dissociation and euphoria and, at higher doses, is an anesthetic. I compare the different routes of ketamine administration, dosages and forms of ketamine, and if micro-dosing ketamine is effective. I also highlight the potential risks of recreational ketamine use (and the colloquial term ‘K-holes’). This episode should interest anyone interested in ketamine, treatments for depression, neuroplasticity mechanisms, psychiatry and mental health. For the full show notes, visit hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman ROKA: https://roka.com/huberman Eight Sleep: https://eightsleep.com/huberman LMNT: https://drinklmnt.com/huberman ROKA: https://roka.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman Timestamps (00:00:00) Ketamine (00:02:29) Sponsors: ROKA & Eight Sleep (00:05:13) Ketamine & PCP; Clinical & Recreational Use (00:09:00) Depression & Current Treatments (00:15:17) Preclinical Models of Depression & Ketamine; “Learned Helplessness” (00:22:11) Ketamine & Clinical Uses; Depression & Suicidality (00:28:32) Ketamine & Other Psychiatric Challenges; Relief & Durability (00:33:24) Sponsor: AG1 (00:34:29) NMDA Receptor & Neuroplasticity (00:41:36) Excitatory & Inhibitory Communication, Seizure, NMDA Receptors & Ketamine (00:48:26) How Ketamine Functions in Brain; Acute & Long-Term Effects (00:55:36) Brain-Derived Neurotrophic Factor (BDNF) & Ketamine Therapy (01:02:28) Sponsor: LMNT (01:03:40) Ketamine & Opioid Pathway (01:10:00) Divergent Mechanisms of Immediate & Long-Term Effects (00:15:45) Habenula, Pro-Depressive Behaviors & Ketamine Therapy (01:20:36) Ketamine & Context-Dependent Strategy; Reward Pathway (01:22:45) Dissociative States (01:26:04) Doses & Routes of Administration; “K-holes”; Risk & Caution (01:32:25) Ketamine Forms; R-, S- vs R/S- Ketamine; Micro-Dosing (01:38:24) Ketamine: Effects & Therapy (01:40:40) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network Newsletter Title Card Photo Credit: Mike Blabac Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to the Huberman Lab podcast where we discuss science and science-based tools for everyday life.

0:09.0

I'm Andrew Huberman and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine.

0:15.0

Today we are discussing ketamine.

0:17.0

Ketamine is a fascinating compound and it's one that nowadays is being used both clinically for the treatment of depression

0:25.0

and suicidality and PTSD and it is also a drug that is commonly abused.

0:32.0

That is ketamine is often used recreationally and it has a high potential for abuse.

0:37.0

So today we are going to discuss both the research on the clinical benefits of ketamine as well as the risks of ketamine.

0:44.0

We are going to discuss the mechanisms of action by which ketamine produces what are called dissociative states.

0:50.0

I will define for you what a so-called K-hole is in scientific terms.

0:54.0

I will talk about dosages of ketamine, I will talk about delivery routes of ketamine and throughout I will be emphasizing both the clinical benefits and the risks.

1:03.0

That is the potential harms of using ketamine out of the appropriate clinical context.

1:08.0

So by the end of today's episode you will understand thoroughly what ketamine is, how it works in the brain and body to produce dissociative states and to relieve depression,

1:17.0

and you will understand how it can actually change neural circuitry.

1:21.0

This is an important thing to understand about ketamine.

1:24.0

The acute or immediate effects of ketamine while one is under the influence of ketamine are just part of the story of how ketamine modifies the brain for the treatment of depression, suicidality and PTSD.

1:36.0

And by extension when people use ketamine recreationally there are those immediate acute effects of ketamine but there are also long term changes in the brain that are important to understand.

1:46.0

During today's discussion we will also be talking a lot about neuroplasticity or your nervous system's ability to change in response to experience.

1:54.0

And we will be talking about neuroplasticity not just in the context of ketamine but as a general theme for how your nervous system changes anytime you learn anything.

2:03.0

And in that discussion you're going to hear a lot about BDNF or Brain Derived Neutrophic Factor.

2:10.0

Brain Derived Neutrophic Factor is a critical molecule for all forms of learning and memory and changes to your nervous system.

2:17.0

So in addition to learning about ketamine and how it works clinically and it's relevance to recreational use and abuse, you will also learn a lot about neuroplasticity and BDNF and what it's doing in your brain right now as you learn.

2:30.0

Before we begin I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scicomm Media, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scicomm Media and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.